Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY Antimicrobial Surveillance Program, 1997 and 1998

被引:231
作者
Fluit, AC
Jones, ME
Schmitz, FJ
Acar, J
Gupta, R
Verhoef, J
机构
[1] Univ Utrecht Hosp, Elijkman Winkler Inst Clin Microbiol, NL-3584 CX Utrecht, Netherlands
[2] Hop St Joseph, Dept Clin Microbiol, F-75674 Paris, France
[3] Bristol Myers Squibb Co, Princeton, NJ USA
关键词
D O I
10.1086/313710
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
As part of the European arm of the SENTRY Antimicrobial Surveillance Program, 25 European university hospitals referred 9613 blood isolates for in vitro testing against >20 antimicrobial agents. Escherichia coli, Staphylococcus aureus, coagulase-negative Staphylococcus, Pseudomonas aeruginosa, and Klebsiella pneumoniae were the 5 most frequent isolates and accounted for two-thirds of all referrals, with minor regional variation. Of these, similar to 0.36% of E. coli and 16.7% of K, pneumoniae isolates proved to be potential extended-spectrum beta-lactamase producers, and their incidence clearly varied regionally Quinolone resistance was detected among gram-negative species; in particular, P. aeruginosa and Acinetobacter species. Considerable regional variation was observed in the incidences of methicillin resistance in S. aureus and penicillin resistance in Streptococcus pneumoniae. The incidence of vancomycin resistance in enterococci was relatively low overall and primarily associated with Enterococcus faecium. However, extrapolation of these data to smaller and nonteaching hospitals should be undertaken with caution, since resistance rates may be lower in these facilities.
引用
收藏
页码:454 / 460
页数:7
相关论文
共 32 条
  • [1] [Anonymous], 1998, M100S8 NCCLS
  • [2] [Anonymous], ANTIMICROB AGENTS S
  • [3] Antimicrobial resistance in isolates from inpatients and outpatients in the united states: Increasing importance of the intensive care unit
    Archibald, L
    Phillips, L
    Monnet, D
    McGowan, JE
    Tenover, F
    Gaynes, R
    [J]. CLINICAL INFECTIOUS DISEASES, 1997, 24 (02) : 211 - 215
  • [4] Acinetobacter spp, as nosocomial pathogens: Microbiological, clinical, and epidemiological features
    BergogneBerezin, E
    Towner, KJ
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (02) : 148 - +
  • [5] Limitation of Acinetobacter baumannii treatment by plasmid-mediated carbapenemase ARI-2
    Brown, S
    Bantar, C
    Young, HK
    Amyes, SGB
    [J]. LANCET, 1998, 351 (9097) : 186 - 187
  • [6] INCIDENCE, RISK-FACTORS, AND OUTCOME OF SEVERE SEPSIS AND SEPTIC SHOCK IN ADULTS - A MULTICENTER PROSPECTIVE-STUDY IN INTENSIVE-CARE UNITS
    BRUNBUISSON, C
    DOYON, F
    CARLET, J
    DELLAMONICA, P
    GOUIN, F
    LEPOUTRE, A
    MERCIER, JC
    OFFENSTADT, G
    REGNIER, B
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (12): : 968 - 974
  • [7] CEFTAZIDIME RESISTANCE AMONG SELECTED NOSOCOMIAL GRAM-NEGATIVE BACILLI IN THE UNITED-STATES
    BURWEN, DR
    BANERJEE, SN
    GAYNES, RP
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (06) : 1622 - 1625
  • [8] EPIDEMIOLOGY OF DRUG-RESISTANCE - IMPLICATIONS FOR A POSTANTIMICROBIAL ERA
    COHEN, ML
    [J]. SCIENCE, 1992, 257 (5073) : 1050 - 1055
  • [9] NATIONAL NOSOCOMIAL INFECTIONS SURVEILLANCE SYSTEM (NNIS) - DESCRIPTION OF SURVEILLANCE METHODS
    EMORI, TG
    CULVER, DH
    HORAN, TC
    JARVIS, WR
    WHITE, JW
    OLSON, DR
    BANERJEE, S
    EDWARDS, JR
    MARTONE, WJ
    GAYNES, RP
    HUGHES, JM
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 1991, 19 (01) : 19 - 35
  • [10] Drug therapy - Antimicrobial-drug resistance
    Gold, HS
    Moellering, RC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (19) : 1445 - 1453